ArticleInternational journal of ophthalmology2025
Impact of residual peripheral anterior synechiae extent on surgical outcomes after viscogonioplasty in primary angle-closure disease.
Article in International journal of ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Peripheral Iris Cerclage in Angle Closure Glaucoma: A Retrospective Pilot Study.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo compare surgical efficacy based on residual peripheral anterior synechiae (PAS) extent after viscogonioplasty (VGP) combined with phacoemulsification and intraocular lens implantation (PEI) in patients with primary angle-closure disease (PACD) and identify risk factors for extensive postoperative PAS.
methodsThis prospective cohort study included 73 eyes of 61 patients with PACD undergoing PEI with VGP. Patients were divided into Group A (PAS<90°,
resultsBoth groups showed significant PAS progression at 12mo (
conclusionResidual PAS extent at the end of surgery predicts postoperative extensive PAS formation but has limited effect on PAS progression rate and IOP control. Female, multiple preoperative IOP-lowering medications, and larger residual PAS extent are independent risk factors for extensive PAS at 12mo postoperatively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.